Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|May 27, 2026
Familial Hyperaldosteronism Type IV (FH-IV)-Clinical Phenotypes, Genetics and Management of CACNA1H-Related Primary Aldosteronism: A Systematic ReviewWojciech Michalski, Igor Jaszczyszyn, Weronika Bielska, et al.
Frontiers in Bioengineering and Biotechnology|April 3, 2026
Models of cartilage repair with autologous mesenchymal stem cells seeded on scaffolds: a systematic narrative reviewMikołaj Wróbel, Hubert Rytel, Igor Jaszczyszyn, et al.
Nucleic Acids Research|November 8, 2021
INDI-integrated nanobody database for immunoinformaticsPiotr Deszyński, Jakub Młokosiewicz, Adam Volanakis, et al.
Bioinformatics (Oxford, England)|March 11, 2022
AbDiver: a tool to explore the natural antibody landscape to aid therapeutic designJakub Młokosiewicz, Piotr Deszyński, Wiktoria Wilman, et al.
Mabs|February 14, 2026
ASD: antigen-specific antibody databaseArkadiusz Czerwiński, Paweł Dudzic, Konrad Wójtowicz, et al.
Cancers|August 12, 2023
Alpha-Fetoprotein Response after First Transarterial Chemoembolization (TACE) and Complete Pathologic Response in Patients with Hepatocellular CancerŁukasz Masior, Maciej Krasnodębski, Mikołaj Kuncewicz, et al.
Communications Biology|July 27, 2025
Conserved heavy/light contacts and germline preferences revealed by a large-scale analysis of natively paired human antibody sequences and structural dataPawel Dudzic, Dawid Chomicz, Weronika Bielska, et al.
Briefings in Bioinformatics|July 13, 2022
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discoveryWiktoria Wilman, Sonia Wróbel, Weronika Bielska, et al.
Frontiers in Molecular Biosciences|July 24, 2023
Structural modeling of antibody variable regions using deep learning-progress and perspectives on drug discoveryIgor Jaszczyszyn, Weronika Bielska, Tomasz Gawlowski, et al.
Mabs|June 6, 2024
Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discoveryPawel Dudzic, Dawid Chomicz, Jarosław Kończak, et al.
Pageof 1